Nordea Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.1M | Buy |
30,496
+3,325
| +12% | +$1.47M | 0.01% | 398 |
|
|
2026
Q1 | $12M | Sell |
27,171
-419,998
| -94% | -$196M | 0.01% | 410 |
|
|
2025
Q4 | $203M | Buy |
447,169
+86,084
| +24% | +$37.1M | 0.17% | 137 |
|
|
2025
Q3 | $140M | Buy |
361,085
+336,573
| +1,373% | +$141M | 0.12% | 181 |
|
|
2025
Q2 | $10.9M | Buy |
24,512
+1,057
| +5% | +$487K | 0.01% | 402 |
|
|
2025
Q1 | $11.4M | Sell |
23,455
-318,974
| -93% | -$149M | 0.01% | 371 |
|
|
2024
Q4 | $138M | Buy |
342,429
+55,739
| +19% | +$25.8M | 0.14% | 168 |
|
|
2024
Q3 | $133M | Sell |
286,690
-66,545
| -19% | -$32M | 0.15% | 176 |
|
|
2024
Q2 | $167M | Buy |
353,235
+21,766
| +7% | +$9.45M | 0.2% | 138 |
|
|
2024
Q1 | $139M | Buy |
331,469
+10,138
| +3% | +$4.29M | 0.16% | 155 |
|
|
2023
Q4 | $131M | Buy |
321,331
+11,259
| +4% | +$4.16M | 0.17% | 155 |
|
|
2023
Q3 | $109M | Buy |
310,072
+21,134
| +7% | +$7.39M | 0.15% | 156 |
|
|
2023
Q2 | $102M | Buy |
288,938
+20,712
| +8% | +$6.98M | 0.14% | 165 |
|
|
2023
Q1 | $84.5M | Sell |
268,226
-31,134
| -10% | -$9.34M | 0.12% | 175 |
|
|
2022
Q4 | $85.9M | Buy |
299,360
+26,599
| +10% | +$8.11M | 0.13% | 176 |
|
|
2022
Q3 | $79.6M | Buy |
272,761
+22,523
| +9% | +$6.48M | 0.13% | 177 |
|
|
2022
Q2 | $69.7M | Sell |
250,238
-19,466
| -7% | -$5.21M | 0.1% | 191 |
|
|
2022
Q1 | $69.6M | Buy |
269,704
+2,710
| +1% | +$643K | 0.09% | 206 |
|
|
2021
Q4 | $59.4M | Buy |
266,994
+29,813
| +13% | +$5.8M | 0.07% | 231 |
|
|
2021
Q3 | $43.7M | Buy |
237,181
+24,564
| +12% | +$4.8M | 0.06% | 266 |
|
|
2021
Q2 | $42.9M | Buy |
212,617
+20,091
| +10% | +$4.2M | 0.06% | 263 |
|
|
2021
Q1 | $41.3M | Buy |
192,526
+53,501
| +38% | +$11.8M | 0.06% | 254 |
|
|
2020
Q4 | $32.9M | Buy |
139,025
+32,422
| +30% | +$7.44M | 0.05% | 263 |
|
|
2020
Q3 | $29M | Sell |
106,603
-73,389
| -41% | -$20.2M | 0.05% | 243 |
|
|
2020
Q2 | $51.7M | Buy |
179,992
+120,034
| +200% | +$32.5M | 0.05% | 239 |
|
|
2020
Q1 | $13.9M | Sell |
59,958
-1,561
| -3% | -$358K | 0.03% | 285 |
|
|
2019
Q4 | $13.4M | Buy |
61,519
+5,613
| +10% | +$1.14M | 0.03% | 315 |
|
|
2019
Q3 | $9.4M | Buy |
55,906
+916
| +2% | +$162K | 0.02% | 343 |
|
|
2019
Q2 | $10.1M | Buy |
54,990
+8,031
| +17% | +$1.4M | 0.02% | 342 |
|
|
2019
Q1 | $8.64M | Buy |
46,959
+33,119
| +239% | +$6.12M | 0.02% | 412 |
|
|
2018
Q4 | $2.29M | Buy |
13,840
+10
| +0.1% | +$1.73K | 0.01% | 805 |
|
|
2018
Q3 | $2.67M | Sell |
13,830
-3,690
| -21% | -$657K | 0.01% | 829 |
|
|
2018
Q2 | $2.98M | Buy |
17,520
+5,275
| +43% | +$818K | 0.01% | 665 |
|
|
2018
Q1 | $2M | Sell |
12,245
-66
| -0.5% | -$10.8K | ﹤0.01% | 752 |
|
|
2017
Q4 | $1.84M | Sell |
12,311
-331
| -3% | -$49K | ﹤0.01% | 731 |
|
|
2017
Q3 | $1.92M | Buy |
12,642
+176
| +1% | +$26.5K | ﹤0.01% | 712 |
|
|
2017
Q2 | $1.61M | Buy |
12,466
+158
| +1% | +$19K | ﹤0.01% | 734 |
|
|
2017
Q1 | $1.35M | Buy |
12,308
+2,223
| +22% | +$196K | ﹤0.01% | 736 |
|
|
2016
Q4 | $743K | Sell |
10,085
-126
| -1% | -$10.3K | ﹤0.01% | 795 |
|
|
2016
Q3 | $891K | Buy |
10,211
+264
| +3% | +$24.9K | ﹤0.01% | 752 |
|
|
2016
Q2 | $856K | Hold |
9,947
| – | – | ﹤0.01% | 569 |
|
|
2016
Q1 | $791K | Hold |
9,947
| – | – | ﹤0.01% | 574 |
|
|
2015
Q4 | $1.25M | Buy |
9,947
+1,346
| +16% | +$162K | ﹤0.01% | 499 |
|
|
2015
Q3 | $896K | Hold |
8,601
| – | – | ﹤0.01% | 464 |
|
|
2015
Q2 | $1.06M | Sell |
8,601
-195
| -2% | -$24.6K | ﹤0.01% | 441 |
|
|
2015
Q1 | $1.04M | Hold |
8,796
| – | – | ﹤0.01% | 446 |
|
|
2014
Q4 | $1.04M | Sell |
8,796
-1,181
| -12% | -$133K | ﹤0.01% | 472 |
|
|
2014
Q3 | $1.12M | Sell |
9,977
-9,734
| -49% | -$927K | ﹤0.01% | 479 |
|
|
2014
Q2 | $1.87M | Hold |
19,711
| – | – | 0.01% | 441 |
|
|
2014
Q1 | $1.39M | Buy |
19,711
+876
| +5% | +$69.4K | 0.01% | 496 |
|
|
2013
Q4 | $1.4M | Buy |
18,835
+1,278
| +7% | +$89K | 0.01% | 509 |
|
|
2013
Q3 | $1.33M | Buy |
17,557
+3,409
| +24% | +$271K | 0.01% | 521 |
|
|
2013
Q2 | $1.13M | Buy |
+14,148
| New | +$1.04M | 0.01% | 554 |
|
Other funds holding VRTX
Nordea Investment Management's VRTX Position: Q2 2026 in Review
Nordea Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, buying an estimated $1.47M and bringing the position to 30,496 shares worth $15.1M. The position accounts for 0.01% of the portfolio, ranked #398.
Nordea Investment Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $203M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Nordea Investment Management held 30,496 shares of Vertex Pharmaceuticals worth $15.1M as of Q2 2026.
- Nordea Investment Management bought 3,325 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.47M.
- Vertex Pharmaceuticals made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #398 holding.
- Nordea Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Nordea Investment Management's Vertex Pharmaceuticals position peaked at $203M in Q4 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.